Related Experiment Videos
Focal segmental glomerulosclerosis and hepatitis C virus: a case report
M Motta1, M Malaguarnera, N Restuccia
1Institute of Internal Medicine and Geriatrics, University of Catania, Catania, Italy.
Panminerva Medica
|April 25, 2001
Summary
Hepatitis C Virus (HCV) infection may cause kidney disease like Focal Segmental Glomerulosclerosis (FSGS). Treating chronic HCV with alpha-IFN improved renal function, suggesting a link between HCV and FSGS.
Area of Science:
- Nephrology
- Hepatology
- Immunology
Background:
- Focal Segmental Glomerulosclerosis (FSGS) is a kidney disease with unknown etiology, often presenting as nephrotic syndrome.
- Hepatitis C Virus (HCV)-related chronic infection is increasingly recognized as a potential cause of kidney disease.
- The pathogenesis of HCV-associated glomerulonephritis requires further elucidation.
Observation:
- A young woman with chronic Hepatitis C Virus (HCV)-Ab positive hepatitis developed kidney involvement consistent with FSGS.
- The patient presented with proteinuria and hematuria, characteristic of nephrotic syndrome.
- No HCV antigens or RNA were detected in the glomerular lesions.
Findings:
- Treatment with alpha-interferon (IFN) for six months led to the simultaneous disappearance of serum HCV-RNA, proteinuria, and hematuria.
- This clinical recovery suggests a potential pathogenetic link between HCV infection and FSGS.
- The absence of detectable viral material in glomeruli does not exclude the virus's role in immune-mediated nephritis.
Implications:
- Alpha-IFN therapy may be effective in managing HCV-related FSGS.
- These findings support the hypothesis that HCV can trigger immunological kidney damage.
- Further research is needed to clarify the precise relationship between HCV and renal syndromes, potentially improving diagnostic and therapeutic strategies.